Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma
Clinical trial NCT04775680 · TERMINATED
Trial details
- NCT number
- NCT04775680
- Sponsor
- Adagene (Suzhou) Limited
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-11
- Primary completion
- 2023-02-09
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.